Our findings suggest that Scriptaid may be a promising drug for managing ACC due to its ability to induce cancer cell death, reduce cancer migration, reduce ALDH+ cancer cells, induce the acetylation of cancer cells, and reduce the levels of the EMT marker Snail. The gene discussed is SNAI1; the disease is cancer.